Israel Successfully Implants Artificial Heart For the First Time in Jerusalem

This is Israel. This is what the Jewish people do.This is what the Jewish people are. And the forces of evil across the world call for it’s destruction. Our enemies worship death, we revere life. Dark times, indeed, my friends.

Wow.

For the FIRST TIME ever in Israel, an ARTIFICIAL HEART was successfully implanted at Hadassah Medical Center, completely replacing the heart of a 63-year-old patient.

While Hamas builds terror tunnels, Israel builds artificial hearts.

While they worship death, we… pic.twitter.com/2Gi4OP6FuS

— Jews Fight Back (@JewsFightBack) May 30, 2025

While Hamas builds terror tunnels, Israel builds artificial hearts.

While they worship death, we innovate life.

From the land they swore we’d never survive on, we’re out here making history, again.

The world’s most advanced artificial heart was implanted in Israel | Watch from the operating room at Sheba Hospital

Huge excitement in operating room number 9 at the Sheba Heart Center: The world’s most advanced artificial heart, Aeson, was implanted into the body of a man in his 50s who suffered from heart failure; The artificial heart will function for a year until a donor heart is found

By Ynet News, May 30, 2025:

The world’s most advanced artificial heart was implanted in Israel | Watch from the operating room at Sheba Hospital
Huge excitement in operating room number 9 at the Sheba Heart Center: The world’s most advanced artificial heart, Aeson, was implanted into the body of a man in his 50s who suffered from heart failure; The artificial heart will function for a year until a donor heart is found

In a groundbreaking procedure on Thursday morning, Sheba Medical Center at Tel HaShomer implanted the world’s most advanced artificial heart—Aeson, developed by French medical device company Carmat—into a man in his 50s suffering from severe biventricular heart failure. The Aeson heart completely replaced the patient’s own, marking a historic moment in Israeli medicine.
Advanced Aeson artificial heart manufactured by Carmat in the operating room at Sheba Medical Center

“This is a very special and historic day,” said Professor Avi Morgan, surgical director of Sheba’s Heart and Artificial Heart Transplant Unit, in an interview with Ynet. The atmosphere outside Operating Room 9 at Sheba’s Heart, Chest and Vascular Center was electric, as residents and staff gathered to witness the medical milestone.

“The artificial heart will keep the patient alive and improve his condition, and we hope that within six to 12 months he will receive a donor heart,” Morgan said. He added that the long-term vision is for the Aeson heart to become a viable alternative to transplantation. “With advancing technology, we believe the artificial heart could eventually become an off-the-shelf product—readily available, without the wait,” he said.

Heart failure affects 1%–2% of the global population—an estimated 80 million to 160 million people. In Israel, around 180,000 people suffer from the condition. While treatments exist, patients with advanced, unmanageable heart failure are often left with one option: a transplant. Yet the global shortage of donor organs means many do not survive the wait.

The new device was implanted in a patient with biventricular failure, where both the left and right sides of the heart cease to function. “Roughly 10% of heart failure patients face this condition, and for them, transplant is often the only option,” said Morgan. But with too few transplants performed annually in Israel, a growing number of patients are in urgent need of alternatives.

Previously, patients with left-side failure could receive a mechanical pump known as an LVAD, which supports circulation by drawing blood from the left ventricle and pumping it through the aorta. However, for those with right- and left-side failure, the only workaround has been implanting two separate LVADs—an option not originally designed for biventricular use and logistically difficult for patients.

The newly implanted Aeson heart, made from a high-performance polymer called PEEK (polyether ether ketone), is engineered to mimic the natural heart’s rhythmic contractions (pulsatility) and adapt in real time to the patient’s physical activity—a process known as autoregulation.

“The artificial heart adjusts to the patient’s activity. If he’s awake or cycling, it knows to pump faster,” explained Yaniv Bakish, clinical support manager at Cemal Medical, the Israeli importer of the technology.
The heart includes four valves and membranes made from biological materials, reducing the risk of blood clots—a common complication in earlier models. Older artificial hearts were bulky, noisy and prone to complications. One previous model was pulled from the market due to high failure rates.

In this procedure, which lasted around six hours, the patient’s heart was removed and replaced with the Aeson device. Initially connected to a heart-lung machine, the patient was gradually weaned off once the new heart was fully operational. The system is externally monitored via a tablet and controlled by a small external power cable, the only component outside the body. It connects to portable batteries or a home power supply at night.

Continued……